Investors & Media

Corporate News

• December 03, 2020Annovis Bio to Present at the New York Academy of Sciences’ Alzheimer's Disease Therapeutics: Alternatives to Amyloid 2020 Virtual Conference
• November 16, 2020Annovis Bio to Participate in A.G.P.'s Virtual Healthcare Symposium
• November 12, 2020Annovis Bio Reports Positive Results from Final Phase of $1.9M NIH Funded Chronic Toxicology Study for its Lead Compound for the Treatment of Alzheimer’s and Parkinson’s Diseases

Neurology News

• October 01, 2019Axonal Transport and Neurological Disease
• May 21, 2019How did the amyloid hypothesis go from promising to perilous in the search for Alzheimer’s treatments?
• April 30, 2019After amyloid failures, it’s time to take a new tack for treating Alzheimer’s

MORE NEUROLOGY NEWS